| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.
|
Med Care
|
2003
|
19.69
|
|
2
|
Screening for lung cancer with low-dose spiral computed tomography.
|
Am J Respir Crit Care Med
|
2002
|
5.10
|
|
3
|
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study.
|
JAMA
|
2006
|
5.06
|
|
4
|
Lung cancer screening with CT: Mayo Clinic experience.
|
Radiology
|
2003
|
4.72
|
|
5
|
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
|
J Clin Oncol
|
2010
|
4.30
|
|
6
|
Burnout and suicidal ideation among U.S. medical students.
|
Ann Intern Med
|
2008
|
3.96
|
|
7
|
Association of resident fatigue and distress with perceived medical errors.
|
JAMA
|
2009
|
3.70
|
|
8
|
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
|
Value Health
|
2008
|
3.68
|
|
9
|
The well-being of physicians.
|
Am J Med
|
2003
|
3.29
|
|
10
|
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
|
Cancer
|
2007
|
3.28
|
|
11
|
Career fit and burnout among academic faculty.
|
Arch Intern Med
|
2009
|
3.15
|
|
12
|
Personal life events and medical student burnout: a multicenter study.
|
Acad Med
|
2006
|
2.98
|
|
13
|
Clinical significance of patient-reported questionnaire data: another step toward consensus.
|
J Clin Epidemiol
|
2005
|
2.98
|
|
14
|
Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.
|
Am J Hematol
|
2009
|
2.84
|
|
15
|
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9.
|
J Clin Oncol
|
2010
|
2.57
|
|
16
|
Responsiveness and minimal important differences for patient reported outcomes.
|
Health Qual Life Outcomes
|
2006
|
2.48
|
|
17
|
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
|
J Clin Oncol
|
2004
|
2.45
|
|
18
|
The relationship between cigarette smoking and quality of life after lung cancer diagnosis.
|
Chest
|
2004
|
2.44
|
|
19
|
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.
|
Support Care Cancer
|
2010
|
2.43
|
|
20
|
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
|
J Natl Cancer Inst
|
2007
|
2.31
|
|
21
|
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial.
|
J Clin Oncol
|
2010
|
2.28
|
|
22
|
Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration.
|
Menopause
|
2009
|
2.27
|
|
23
|
Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial.
|
J Clin Oncol
|
2006
|
2.22
|
|
24
|
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.
|
Cancer Res
|
2010
|
2.19
|
|
25
|
A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students.
|
Mayo Clin Proc
|
2006
|
2.14
|
|
26
|
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
|
Gynecol Oncol
|
2003
|
2.11
|
|
27
|
How do distress and well-being relate to medical student empathy? A multicenter study.
|
J Gen Intern Med
|
2007
|
2.10
|
|
28
|
Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
|
J Clin Oncol
|
2002
|
2.09
|
|
29
|
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance.
|
J Clin Oncol
|
2005
|
2.09
|
|
30
|
The Impact of Stigma and Personal Experiences on the Help-Seeking Behaviors of Medical Students With Burnout.
|
Acad Med
|
2015
|
2.06
|
|
31
|
Phase III evaluation of fluoxetine for treatment of hot flashes.
|
J Clin Oncol
|
2002
|
1.97
|
|
32
|
Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
|
Ophthalmology
|
2006
|
1.96
|
|
33
|
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
|
Cancer
|
2007
|
1.94
|
|
34
|
Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.
|
J Clin Oncol
|
2004
|
1.90
|
|
35
|
Patterns of distress in US medical students.
|
Med Teach
|
2011
|
1.87
|
|
36
|
Avoiding burnout: the personal health habits and wellness practices of US surgeons.
|
Ann Surg
|
2012
|
1.85
|
|
37
|
Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.
|
J Pain Symptom Manage
|
2007
|
1.83
|
|
38
|
Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation.
|
Radiology
|
2002
|
1.79
|
|
39
|
The learning environment and medical student burnout: a multicentre study.
|
Med Educ
|
2009
|
1.79
|
|
40
|
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.
|
J Clin Oncol
|
2008
|
1.77
|
|
41
|
Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.
|
J Clin Oncol
|
2006
|
1.76
|
|
42
|
Physician satisfaction and burnout at different career stages.
|
Mayo Clin Proc
|
2013
|
1.75
|
|
43
|
Quality of life and symptom burden among long-term lung cancer survivors.
|
J Thorac Oncol
|
2012
|
1.74
|
|
44
|
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
|
Cancer
|
2008
|
1.73
|
|
45
|
The medical marriage: a national survey of the spouses/partners of US physicians.
|
Mayo Clin Proc
|
2013
|
1.67
|
|
46
|
Glutamine does not prevent paclitaxel-associated myalgias and arthralgias.
|
J Support Oncol
|
2004
|
1.66
|
|
47
|
Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.
|
J Clin Oncol
|
2002
|
1.65
|
|
48
|
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.
|
J Clin Oncol
|
2011
|
1.65
|
|
49
|
Personal consequences of malpractice lawsuits on American surgeons.
|
J Am Coll Surg
|
2011
|
1.64
|
|
50
|
Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions.
|
J Am Acad Orthop Surg
|
2010
|
1.63
|
|
51
|
Burnout and serious thoughts of dropping out of medical school: a multi-institutional study.
|
Acad Med
|
2010
|
1.63
|
|
52
|
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.
|
J Clin Oncol
|
2010
|
1.61
|
|
53
|
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes.
|
Qual Life Res
|
2010
|
1.61
|
|
54
|
The prevalence of weight concerns in a smoking abstinence clinical trial.
|
Addict Behav
|
2005
|
1.60
|
|
55
|
Quality of life after breast cancer surgery: What have we learned and where should we go next?
|
J Surg Oncol
|
2009
|
1.60
|
|
56
|
Single item measures of emotional exhaustion and depersonalization are useful for assessing burnout in medical professionals.
|
J Gen Intern Med
|
2009
|
1.59
|
|
57
|
Pilot evaluation of black cohosh for the treatment of hot flashes in women.
|
Cancer Invest
|
2004
|
1.55
|
|
58
|
An interactive individualized intervention to promote behavioral change to increase personal well-being in US surgeons.
|
Ann Surg
|
2014
|
1.52
|
|
59
|
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.
|
J Neurooncol
|
2006
|
1.50
|
|
60
|
Pilot evaluation of gabapentin for treating hot flashes.
|
Mayo Clin Proc
|
2002
|
1.48
|
|
61
|
Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.
|
J Natl Cancer Inst
|
2013
|
1.47
|
|
62
|
Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis.
|
Radiology
|
2006
|
1.46
|
|
63
|
Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.
|
J Pain Symptom Manage
|
2010
|
1.46
|
|
64
|
Factors associated with resilience to and recovery from burnout: a prospective, multi-institutional study of US medical students.
|
Med Educ
|
2010
|
1.45
|
|
65
|
Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation.
|
Support Care Cancer
|
2002
|
1.44
|
|
66
|
Race, ethnicity, and medical student well-being in the United States.
|
Arch Intern Med
|
2007
|
1.41
|
|
67
|
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.
|
Cancer
|
2003
|
1.41
|
|
68
|
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.
|
Cancer
|
2008
|
1.40
|
|
69
|
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
|
J Clin Oncol
|
2004
|
1.40
|
|
70
|
Distress among matriculating medical students relative to the general population.
|
Acad Med
|
2014
|
1.37
|
|
71
|
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
|
J Clin Oncol
|
2003
|
1.36
|
|
72
|
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma.
|
Blood
|
2002
|
1.34
|
|
73
|
The truly remarkable universality of half a standard deviation: confirmation through another look.
|
Expert Rev Pharmacoecon Outcomes Res
|
2004
|
1.34
|
|
74
|
Preferred roles in treatment decision making among patients with cancer: a pooled analysis of studies using the Control Preferences Scale.
|
Am J Manag Care
|
2010
|
1.32
|
|
75
|
The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.
|
Cancer
|
2013
|
1.30
|
|
76
|
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.
|
Support Care Cancer
|
2009
|
1.28
|
|
77
|
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial.
|
Cancer
|
2012
|
1.25
|
|
78
|
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.
|
Pain
|
2002
|
1.24
|
|
79
|
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
|
Cancer
|
2012
|
1.24
|
|
80
|
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival.
|
Neurosurgery
|
2005
|
1.23
|
|
81
|
Motivational readiness for physical activity and quality of life in long-term lung cancer survivors.
|
Lung Cancer
|
2008
|
1.23
|
|
82
|
ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.
|
J Pain Symptom Manage
|
2010
|
1.23
|
|
83
|
Relationship of pass/fail grading and curriculum structure with well-being among preclinical medical students: a multi-institutional study.
|
Acad Med
|
2011
|
1.23
|
|
84
|
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
|
Mayo Clin Proc
|
2006
|
1.20
|
|
85
|
Role of a medical social worker in improving quality of life for patients with advanced cancer with a structured multidisciplinary intervention.
|
J Psychosoc Oncol
|
2007
|
1.19
|
|
86
|
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
|
Mayo Clin Proc
|
2007
|
1.19
|
|
87
|
Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
|
J Palliat Med
|
2005
|
1.17
|
|
88
|
Development and preliminary psychometric properties of a well-being index for medical students.
|
BMC Med Educ
|
2010
|
1.16
|
|
89
|
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.
|
Br J Haematol
|
2007
|
1.15
|
|
90
|
Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer.
|
Cancer
|
2012
|
1.15
|
|
91
|
Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
|
J Clin Oncol
|
2006
|
1.14
|
|
92
|
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.
|
Cancer
|
2007
|
1.14
|
|
93
|
Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout assessment.
|
J Gen Intern Med
|
2012
|
1.13
|
|
94
|
Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
|
J Clin Oncol
|
2003
|
1.13
|
|
95
|
Measuring outcomes in randomized prospective trials in palliative care.
|
J Pain Symptom Manage
|
2007
|
1.13
|
|
96
|
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.
|
Support Care Cancer
|
2011
|
1.12
|
|
97
|
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.
|
J Thorac Oncol
|
2009
|
1.12
|
|
98
|
Interpreting and reporting results based on patient-reported outcomes.
|
Value Health
|
2007
|
1.12
|
|
99
|
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
|
Cancer
|
2005
|
1.11
|
|
100
|
Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer.
|
Psychooncology
|
2002
|
1.11
|
|
101
|
Complementary and alternative medicine use by patients enrolled onto phase I clinical trials.
|
J Clin Oncol
|
2004
|
1.10
|
|
102
|
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146).
|
Ann Surg Oncol
|
2011
|
1.09
|
|
103
|
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
|
Breast Cancer Res Treat
|
2009
|
1.09
|
|
104
|
Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force.
|
Cancer
|
2012
|
1.08
|
|
105
|
Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.
|
Cancer
|
2008
|
1.08
|
|
106
|
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.07
|
|
107
|
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
|
Nicotine Tob Res
|
2003
|
1.07
|
|
108
|
Therapeutic exercise during outpatient radiation therapy for advanced cancer: Feasibility and impact on physical well-being.
|
Am J Phys Med Rehabil
|
2010
|
1.06
|
|
109
|
Work-home conflicts have a substantial impact on career decisions that affect the adequacy of the surgical workforce.
|
Arch Surg
|
2012
|
1.05
|
|
110
|
Work/Home conflict and burnout among academic internal medicine physicians.
|
Arch Intern Med
|
2011
|
1.04
|
|
111
|
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.
|
Breast
|
2010
|
1.03
|
|
112
|
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
|
Support Care Cancer
|
2010
|
1.03
|
|
113
|
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
|
Cancer
|
2007
|
1.03
|
|
114
|
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.
|
Twin Res Hum Genet
|
2009
|
1.03
|
|
115
|
Measuring spiritual quality of life in patients with cancer.
|
J Support Oncol
|
2007
|
1.03
|
|
116
|
Palliative care consultations in patients with cancer: a mayo clinic 5-year review.
|
J Oncol Pract
|
2011
|
1.02
|
|
117
|
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.02
|
|
118
|
Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.01
|
|
119
|
Comparison of frail patients versus nonfrail patients ≥65 years of age undergoing percutaneous coronary intervention.
|
Am J Cardiol
|
2012
|
0.99
|
|
120
|
Quality of life of caregivers of patients with advanced-stage cancer.
|
Am J Hosp Palliat Care
|
2006
|
0.97
|
|
121
|
Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience.
|
Menopause
|
2008
|
0.96
|
|
122
|
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.
|
Gynecol Oncol
|
2003
|
0.96
|
|
123
|
Efficacy of a brief screening tool to identify medical students in distress.
|
Acad Med
|
2011
|
0.96
|
|
124
|
Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: a randomized controlled trial.
|
Palliat Support Care
|
2007
|
0.96
|
|
125
|
The need for and characteristics of randomized, phase III trials to evaluate symptom management in patients with cancer.
|
J Natl Cancer Inst
|
2002
|
0.96
|
|
126
|
Newer antidepressants for hot flashes--should their efficacy still be up for debate?
|
Menopause
|
2009
|
0.95
|
|
127
|
Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
|
J Clin Oncol
|
2006
|
0.95
|
|
128
|
Relationship of optimism-pessimism and health-related quality of life in breast cancer survivors.
|
J Psychosoc Oncol
|
2008
|
0.95
|
|
129
|
Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?
|
Am J Clin Oncol
|
2006
|
0.95
|
|
130
|
Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey.
|
J Heart Lung Transplant
|
2012
|
0.94
|
|
131
|
Genetic determinants of lung cancer short-term survival: the role of glutathione-related genes.
|
Lung Cancer
|
2002
|
0.93
|
|
132
|
Association of optimism-pessimism with quality of life in patients with head and neck and thyroid cancers.
|
Mayo Clin Proc
|
2006
|
0.93
|
|
133
|
Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.
|
J Clin Oncol
|
2002
|
0.92
|
|
134
|
Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide.
|
Clin Pharmacol Ther
|
2002
|
0.91
|
|
135
|
Towards the prevention of acute lung injury: a population based cohort study protocol.
|
BMC Emerg Med
|
2010
|
0.91
|
|
136
|
Pilot evaluation of flaxseed for the management of hot flashes.
|
J Soc Integr Oncol
|
2007
|
0.91
|
|
137
|
Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.
|
Leuk Res
|
2007
|
0.91
|
|
138
|
Qualitative and quantitative analysis of women's perceptions of transvaginal surgery.
|
Surg Endosc
|
2011
|
0.90
|
|
139
|
Pilot evaluation of paroxetine for treating hot flashes in men.
|
Mayo Clin Proc
|
2004
|
0.90
|
|
140
|
A multi-institutional study exploring the impact of positive mental health on medical students' professionalism in an era of high burnout.
|
Acad Med
|
2012
|
0.90
|
|
141
|
Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4).
|
Oncologist
|
2010
|
0.88
|
|
142
|
Rising importance of patient-reported outcomes.
|
Lancet Oncol
|
2006
|
0.88
|
|
143
|
Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis.
|
Mayo Clin Proc
|
2004
|
0.88
|
|
144
|
Quality of life measurements: a soft outcome--or is it?
|
Am J Manag Care
|
2002
|
0.88
|
|
145
|
Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia.
|
Clin Cancer Res
|
2005
|
0.88
|
|
146
|
Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions.
|
Explore (NY)
|
2011
|
0.87
|
|
147
|
Whose opinion counts?
|
J Clin Oncol
|
2006
|
0.87
|
|
148
|
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update.
|
Qual Life Res
|
2014
|
0.86
|
|
149
|
Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
|
Am J Clin Oncol
|
2003
|
0.86
|
|
150
|
Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA.
|
J Clin Oncol
|
2008
|
0.86
|
|
151
|
Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial.
|
J Clin Oncol
|
2007
|
0.86
|
|
152
|
Therapy-related symptom checklist use during treatments at a cancer center.
|
Cancer Nurs
|
2013
|
0.86
|
|
153
|
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
|
J Thorac Oncol
|
2009
|
0.85
|
|
154
|
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
|
Support Care Cancer
|
2012
|
0.85
|
|
155
|
Is it simple or simplistic?
|
Med Care
|
2003
|
0.85
|
|
156
|
The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia.
|
Leuk Res
|
2008
|
0.85
|
|
157
|
A pessimistic explanatory style is prognostic for poor lung cancer survival.
|
J Thorac Oncol
|
2010
|
0.85
|
|
158
|
Spiritual well-being and quality of life of women with ovarian cancer and their spouses.
|
J Support Oncol
|
2011
|
0.85
|
|
159
|
Building resiliency: a cross-sectional study examining relationships among health-related quality of life, well-being, and disaster preparedness.
|
Health Qual Life Outcomes
|
2014
|
0.84
|
|
160
|
Paced breathing compared with usual breathing for hot flashes.
|
Menopause
|
2013
|
0.84
|
|
161
|
The hospice patient's primary caregiver. What is their quality of life?
|
J Psychosom Res
|
2003
|
0.84
|
|
162
|
Physical activity level and quality of life in long term lung cancer survivors.
|
Lung Cancer
|
2012
|
0.84
|
|
163
|
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
|
Cancer
|
2008
|
0.83
|
|
164
|
A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors.
|
Cancer Chemother Pharmacol
|
2005
|
0.83
|
|
165
|
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
|
Anticancer Drugs
|
2005
|
0.83
|
|
166
|
A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors.
|
Clin Cancer Res
|
2002
|
0.83
|
|
167
|
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.
|
Clin Cancer Res
|
2003
|
0.83
|
|
168
|
Meeting on the FDA draft guidance on patient-reported outcomes.
|
Value Health
|
2007
|
0.82
|
|
169
|
Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N00CA.
|
Support Care Cancer
|
2012
|
0.82
|
|
170
|
A prospective study of the relationship between medical knowledge and professionalism among internal medicine residents.
|
Acad Med
|
2007
|
0.82
|
|
171
|
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).
|
J Support Oncol
|
2011
|
0.82
|
|
172
|
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
|
Am J Obstet Gynecol
|
2011
|
0.82
|
|
173
|
A brief Patient-Reported Outcomes Quality of Life (PROQOL) instrument to improve patient care.
|
PLoS Med
|
2013
|
0.82
|
|
174
|
A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.
|
Clin Cancer Res
|
2003
|
0.81
|
|
175
|
Health related quality of life in patients with Charcot arthropathy of the foot and ankle.
|
Foot Ankle Surg
|
2007
|
0.81
|
|
176
|
Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB).
|
Support Care Cancer
|
2009
|
0.81
|
|
177
|
PROMIS for Laparoscopy.
|
J Gastrointest Surg
|
2015
|
0.81
|
|
178
|
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.
|
Am J Clin Oncol
|
2003
|
0.81
|
|
179
|
Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial.
|
Support Care Cancer
|
2004
|
0.80
|
|
180
|
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).
|
Support Care Cancer
|
2011
|
0.80
|
|
181
|
Is the use of QOL data really any different than other medical testing?
|
Curr Probl Cancer
|
2006
|
0.80
|
|
182
|
Marital status and quality of life in patients with esophageal cancer or Barrett's esophagus: the mayo clinic esophageal adenocarcinoma and Barrett's esophagus registry study.
|
Dig Dis Sci
|
2010
|
0.80
|
|
183
|
Caregivers of patients with cancer fatigue: a high level of symptom burden.
|
Am J Hosp Palliat Care
|
2013
|
0.80
|
|
184
|
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
|
Cancer
|
2011
|
0.79
|
|
185
|
Spiritual well-being in lung cancer survivors.
|
Support Care Cancer
|
2013
|
0.79
|
|
186
|
Levetiracetam for the treatment of hot flashes: a phase II study.
|
Support Care Cancer
|
2007
|
0.79
|
|
187
|
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.
|
Cancer
|
2013
|
0.79
|
|
188
|
The relation between cancer patient treatment decision-making roles and quality of life.
|
Cancer
|
2013
|
0.79
|
|
189
|
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
|
Cancer Chemother Pharmacol
|
2005
|
0.79
|
|
190
|
Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).
|
Cancer
|
2014
|
0.79
|
|
191
|
Perioperative patient-reported outcomes predict serious postoperative complications: a secondary analysis of the COST trial.
|
J Gastrointest Surg
|
2014
|
0.78
|
|
192
|
Pilot evaluation of aprepitant for the treatment of hot flashes.
|
Support Cancer Ther
|
2006
|
0.78
|
|
193
|
Effect of 24-hour mandatory vs on-demand critical care specialist presence on long-term survival and quality of life of critically ill patients in the intensive care unit of a teaching hospital.
|
J Crit Care
|
2011
|
0.78
|
|
194
|
An exploratory pilot study of palliative medicine compared to anesthesia-pain consultation for pain in patients with cancer.
|
J Support Oncol
|
2011
|
0.77
|
|
195
|
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA.
|
J Support Oncol
|
2011
|
0.77
|
|
196
|
On appetite and its loss.
|
J Clin Oncol
|
2003
|
0.77
|
|
197
|
The problems program directors inherit: medical student distress at the time of graduation.
|
Med Teach
|
2011
|
0.77
|
|
198
|
Impact of a structured multidisciplinary intervention on quality of life of older adults with advanced cancer.
|
Int Psychogeriatr
|
2013
|
0.76
|
|
199
|
Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?
|
Support Care Cancer
|
2013
|
0.76
|
|
200
|
A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults.
|
Cancer Manag Res
|
2010
|
0.76
|
|
201
|
American ginseng (Panax quinquefolius) administration does not affect performance of the Roche COBAS Ampliprep/Taqman HIV-1 RNA assay.
|
BMC Complement Altern Med
|
2014
|
0.75
|
|
202
|
Facebook: can it be a diagnostic tool for neurologists?
|
BMJ Case Rep
|
2012
|
0.75
|
|
203
|
Quality-of-life meta-analysis: why treat it differently?
|
J Clin Oncol
|
2003
|
0.75
|
|
204
|
Spiritual quality of life in advanced cancer patients receiving radiation therapy.
|
Psychooncology
|
2013
|
0.75
|
|
205
|
North Central Cancer Treatment Group--achievements and perspectives.
|
Semin Oncol
|
2008
|
0.75
|
|
206
|
Acupuncture for treatment of noncyclic breast pain: a pilot study.
|
Am J Chin Med
|
2011
|
0.75
|
|
207
|
A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer.
|
Invest New Drugs
|
2002
|
0.75
|
|
208
|
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
|
Am J Ther
|
2006
|
0.75
|
|
209
|
Patient-Reported Outcomes after Laparoscopic Ventral Hernia Repair.
|
Am Surg
|
2016
|
0.75
|
|
210
|
Assessment of quality of life outcomes in the treatment of advanced colorectal malignancies.
|
Gastroenterol Clin North Am
|
2006
|
0.75
|
|
211
|
Distress and empathy do not drive changes in specialty preference among US medical students.
|
Med Teach
|
2012
|
0.75
|
|
212
|
End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care.
|
BMJ Support Palliat Care
|
2013
|
0.75
|
|
213
|
Erratum to: Genetic variations underlying self-reported physical functioning: a review.
|
Qual Life Res
|
2015
|
0.75
|
|
214
|
Genetic variations underlying self-reported physical functioning: a review.
|
Qual Life Res
|
2014
|
0.75
|